Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case–control analysis

Using a Test-Negative Case-Control Analysis, Dr Margaret L. Lind and colleagues, investigate the association between primary or booster COVID-19 mRNA vaccination and omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection.

Related Keywords

Connecticut ,United States ,New York ,Beijing ,China ,Rhode Island ,Shenzhen ,Guangdong ,Yale University ,Elvin Hsing Geng ,Revelar Biotherapeutics ,Beatrice Kleinberg Neuwirth ,Glaxosmithkline ,University Of Florida ,Health Information ,Refactor Health ,Shenzhen Center ,Yale New Haven Health ,Care Everywhere Network ,Regeneron Pharmaceuticals ,Program Of Merck Sharp Dohme Corp Title ,National Center ,Yale Human Research Protection Program ,Yale New Haven Health System ,Sendas Family Fund ,Yale Computational Health Platform ,Hugo Health ,Yale Schools Of Public Health ,Reckitt Global Hygiene Institute ,Severe Acute Respiratory Syndrome Coronavirus ,Thermo Fisher Scientific ,Washington University ,Creative Commons Attribution License ,Yale Schools ,Public Health ,Investigator Initiated Studies Program ,Merck Sharp ,Dohme Corp ,Harnessing Large Cohorts ,Rapid Knowledge Pipeline ,Elucidate Immunity ,Tata Medical ,Cardiovascular Diseases ,Regeneron Pharmaceutical ,Coronavirus Disease ,Everywhere Network ,Yale Institutional Review Board ,Observational Studies ,Daily Omicron ,Booster Doses ,Virus Testing ,Sars Cov 2 ,Respiratory Infections ,Covid 19 ,Reverse Transcriptase Polymerase Chain Reaction ,Medical Risk Factors ,Vaccination And Immunization ,